Pharvaris

-$0.47 (-2.62%) Today
-$0.29 (-1.66%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pharvaris and other ETFs, options, and stocks.

About PHVS

Pharvaris NV operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases.

CEO
Berndt A. E. Modig
Employees
34
Headquarters
Leiden, Zuid-Holland
Founded
2015

PHVS Key Statistics

Market cap
579.83M
Price-Earnings ratio
—
Dividend yield
—
Average volume
5.78K
High today
$17.91
Low today
$17.49
Open price
$17.91
Volume
956.00
52 Week high
$22.00
52 Week low
$13.14

PHVS Earnings

-$6.40
-$4.27
-$2.13
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Jul 29, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure